Cargando…

Physical Activity and Benign Prostatic Hyperplasia-Related Outcomes and Nocturia

INTRODUCTION: Benign prostatic hyperplasia (BPH) and its associated lower urinary tract symptoms (LUTS), including nocturia, are extremely common among middle- and older-age American men. Although studies on physical activity (PA) and prevalent BPH-related outcomes suggest that PA may protect agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	WOLIN, KATHLEEN Y., GRUBB, ROBERT L., PAKPAHAN, RATNA, RAGARD, LAWRENCE, MABIE, JEROME, ANDRIOLE, GERALD L., SUTCLIFFE, SIOBHAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342314/ https://www.ncbi.nlm.nih.gov/pubmed/25010403 http://dx.doi.org/10.1249/MSS.0000000000000444

Ejemplares similares

Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia
por: Khan, Saira, et al.
Publicado: (2021)

Changes in Nocturia after Photoselective Vaporization of the Prostate for Patients with Benign Prostatic Hyperplasia
por: Lee, Chang Ju, et al.
Publicado: (2010)

A novel approach to management of nocturia in patients with benign prostatic hyperplasia
por: Sengottayan, Vengetesh K., et al.
Publicado: (2009)

Effect of Nocturia on Quality of Life among Clients with Benign Prostatic Hyperplasia
por: Varughese, Susamma, et al.
Publicado: (2021)

Long-Term Effect of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia
por: Shin, Hong Il, et al.
Publicado: (2011)

Efficacy of combination therapy with tamsulosin and zolpidem on nocturia in patients with benign prostatic hyperplasia
por: Miwa, Kousei, et al.
Publicado: (2011)

Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018)

Levels and patterns of self‐reported and objectively‐measured free‐living physical activity among prostate cancer survivors: A prospective cohort study
por: Smith, Lee, et al.
Publicado: (2018)

Benign prostatic hyperplasia and subsequent risk of bladder cancer
por: Kang, D, et al.
Publicado: (2007)

Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

One-year urinary and sexual outcome trajectories among prostate cancer patients treated by radical prostatectomy: a prospective study
por: Yang, Lin, et al.
Publicado: (2021)

The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study
por: Xue, Zhigang, et al.
Publicado: (2018)

Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study
por: Peng, Yi-Hao, et al.
Publicado: (2017)

Prostatic hyperplasia is highly associated with nocturia and excessive sleepiness: a cross-sectional study
por: Chartier-Kastler, Emmanuel, et al.
Publicado: (2012)

Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study
por: Zhang, Weiyu, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
por: Shebl, F M, et al.
Publicado: (2012)

Is birthweight associated with total and aggressive/lethal prostate cancer risks? A systematic review and meta-analysis
por: Zhou, Cindy Ke, et al.
Publicado: (2016)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Physical activity and risk of colon adenoma: a meta-analysis
por: Wolin, K Y, et al.
Publicado: (2011)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

The Study About Physical Activity for Subjects With Prevention of Benign Prostate Hyperplasia
por: Lee, Ho Won, et al.
Publicado: (2014)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Pharmacotherapy for Nocturia
por: Andersson, Karl-Erik, et al.
Publicado: (2018)

Accuracy of a “Single Question Nocturia Score” compared to the “International Prostate Symptoms Score” in the evaluation of lower urinary tract symptoms in benign prostatic hyperplasia: A study performed at Ndola Teaching Hospital, Ndola, Zambia
por: Kajimotu, Teddy, et al.
Publicado: (2018)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_si45k4i94nr5rpr22k5b3f4qor